How to price botox & filler treatments: a medspa operator's guide

Per-unit vs per-area pricing models, membership and package structures, dynamic pricing for peak demand, and how to use your COGS data to set prices that are both competitive and profitable — grounded in Zenoti's 2026 Benchmark Report data.

There are three Botox pricing models: per-unit ($10–$18), per-area (fixed price per treatment zone), and per-session (flat rate for a full treatment plan). The best default is per-unit — transparent and COGS-aligned — with per-area bundles for new patients and flat-rate session pricing for your VIP tier. Set prices from your actual cost of goods ($327–$382 for a 40-unit treatment), not just competitor benchmarking. The 2026 benchmark shows a $268 gap between the median medspa ticket ($216) and the 90th percentile ($484) — that gap is pricing and service mix, not volume.

• $484 90th-percentile medspa ticket 2025 — trending back toward $500 seen in 2023
• $216 Median medspa ticket 2025. The $268 gap is the pricing opportunity.
• $4.25M Annual revenue per location at 90th percentile vs $1.86M at the median

Source: Zenoti 2026 Beauty and Wellness Benchmark Report

Introduction: the most consequential, least analytical decision in the medspa

Injectable pricing is one of the most consequential decisions a medspa operator makes — and one of the least analytically grounded. Most clinics set prices by looking at what competitors charge, adding a small differential, and leaving it there. That approach tells you what the market will bear, but not whether those prices are profitable given your specific cost structure — or whether your positioning actually reflects the provider quality and patient experience you're delivering.

This guide walks through the three dominant injectable pricing models, how to build prices from your actual cost of goods, where the benchmark data says the medspa market is heading on ticket size, and how membership and package structures change the economics of an injectable practice.

Section 01 — Botox pricing models: per-unit vs per-area vs per-session

There are three main approaches to pricing injectable treatments. Each has advantages and disadvantages depending on your clinic's clinical approach, patient demographics, and competitive positioning.

💉Per-unit pricing

Typical range: $10–$18 per unit for Botox at current market rates

• ✓ Most transparent — patients understand exactly what they're paying for
• ✓ Aligns revenue directly with product cost; COGS scales with revenue
• ✓ Favoured by experienced patients who know their unit requirements

• ✗ Patients may resist adding units mid-treatment ("do I really need those extra 5 units?")

📍Per-area pricing

Typical range: $249–$350 per treatment area (e.g., $350 glabella, $299 crow's feet)

• ✓ Predictable revenue per treatment area — easier for patients to budget
• ✓ Removes the "haggling" dynamic about unit counts
• ✓ Popular in franchise models with standardised protocols

• ✗ Margin erodes if patient needs more units than the area price assumes
• ✗ COGS harder to manage when providers use varying unit counts for the same area

⭐Per-session (flat-rate) pricing

Typical range: "Full-Face Neurotoxin Session $799" covering all standard areas

• ✓ Highest average ticket — perceived as comprehensive, premium experience
• ✓ Provider has clinical autonomy to use units optimally without patient micromanagement
• ✓ Works best with experienced providers and established patient trust

• ✗ Less suitable for new patients who want transparency about what they're receiving
• ✗ Requires strong clinical record-keeping to track COGS against flat session revenue

★ Which model is right for your clinic?

Most successful injectable practices use a hybrid: per-unit pricing as the default (transparent, COGS-aligned), with per-area bundles available for new patients who find unit counts confusing, and flat-rate session pricing reserved for their VIP or established patient tier. The important thing is that your software supports all three models and can calculate COGS accurately regardless of which pricing method is used.

Section 02 — COGS-based botox pricing: building prices from your actual costs

Most injectable clinics set prices by benchmarking competitors. That approach tells you what the market will bear — but not whether those prices are profitable given your specific cost structure. COGS-based pricing starts from your actual costs and works upward.

The Botox treatment cost breakdown: what a 40-unit session really costs

For a 40-unit Botox treatment using product purchased at $6/unit:

* Provider labour and overhead vary significantly by market, provider credentials, and clinic location. These are illustrative ranges — calculate your own figures. Product cost-per-unit should be your perpetual average cost across purchase history, not the latest invoice price (covered in Article 1).

At $327–$382 COGS for a 40-unit treatment, pricing at $14/unit ($560) yields a gross margin of approximately 32–42%. That's a healthy margin — but it's completely invisible without unit-level inventory tracking that calculates COGS per treatment automatically. That tracking layer — perpetual average costing, waste attribution, per-treatment deduction — is covered in Article 1 of this guide.

Pricing for different neurotoxin products

Daxxify and Xeomin typically command a premium over standard Botox — Daxxify because of its longer duration (6–9 months), Xeomin because of its "naked toxin" formulation and allergy profile. If you offer multiple products, structure your pricing to reflect:

• The actual cost-per-unit difference between products
• The value premium patients will pay for longer duration (Daxxify at 1.5–2× standard Botox is common)
• The competitive dynamics in your market — what is the nearest Daxxify provider charging?

Section 03 — Medspa pricing strategy: how much should you charge for botox?

Your pricing signals your positioning. Significantly below-market pricing communicates discount rather than value. Premium pricing requires supporting evidence — provider credentials, results quality, patient experience, and reputation.

📉Volume / Accessible - $9–$12/unit

What supports it: High appointment volume, efficiency focus, new patient acquisition

Risk: Margin risk at $6+ COGS per unit — $9/unit pricing leaves very thin margin after overhead

⚖️Mid-market - $13–$16/unit

What supports it: Experienced providers, established reputation, consistent results documentation

Risk: Competitive — most clinics in this range; differentiation requires service quality

✨Premium / Luxury - $17–$25+/unit

What supports it: Board-certified physician injectors, before/after portfolio, premium brand experience, exclusive product access

Risk: Sustainable when positioning is credible — highest margin, often best retention

Section 04 — Botox package pricing & injectable membership economics

Transactional per-unit pricing captures one appointment's revenue. Package and membership models capture the lifetime value of the treatment cycle — and create committed recurring revenue that smooths the clinic's cashflow. (This section covers the pricing economics; the retention strategy behind memberships is Article 5's territory, and the programme mechanics live in Zenoti's membership programme software.)

Treatment packages

Pre-purchase bundles that offer a discount in exchange for commitment. Common models:

• Unit bundles: Buy 100 units at $12.50/unit (vs standard $14) — valid for 12 months. Patient has committed capital, clinic has committed revenue.
• Area packages: Buy 3 full-face sessions at 15% off. Upfront payment locks in 3 appointment cycles.
• Treatment combos: "Botox + lip filler" package at 10% off combined — drives higher average ticket and introduces patients to multi-service treatments.

Membership programme economics

★ The recurring revenue case

A clinic with 100 active membership patients at an average of $149/month generates $178,800 in predictable annual revenue — before any transactional treatment fees. Medspa membership sales grew 13% in 2025, with the Benchmark Report noting this as "a clear opportunity to capture recurring revenue more deliberately." The treatment cycle model of injectables is the natural foundation for a membership programme: the cadence is already there. Memberships just make it committed.

Section 05 — Dynamic pricing for medspas: capturing peak-demand value

Static pricing leaves revenue on the table during high-demand periods. Dynamic pricing adjusts service rates based on demand, provider availability, and timing — in a controlled, transparent way that patients accept when it's implemented well. (This section covers how to run it operationally; the feature itself is Zenoti's dynamic pricing software.)

How dynamic pricing works for injectables

• Peak-period premium: Friday afternoon slots and pre-event appointments (pre-holiday, pre-wedding season) command premium pricing — $1–2 more per unit, or $25–50 more per area treatment
• Off-peak incentive: Tuesday morning appointments are harder to fill — slightly reduced pricing or a bonus add-on (complimentary lip flip with full-face Botox) fills the schedule without discounting the core service
• Last-minute availability: Same-day slots that would otherwise go empty can be offered at a modest discount via automated outreach to the waitlist — filling the chair rather than losing the revenue entirely
• Seasonal positioning: Pre-summer (April/May) and pre-holiday (November) are the highest-demand windows. Promotional packages during lower-demand months (January, August) smooth the revenue curve

Pricing transparency: communicating dynamic pricing to patients

Dynamic pricing for aesthetic services requires careful framing. Patients should understand that:

• Standard rates apply at most appointment times — dynamic pricing affects a defined subset of slots
• Off-peak pricing represents genuine value, not a compromise in service quality
• Membership rates are fixed regardless of when the appointment occurs — memberships provide price stability